DW-14383

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameDW-14383
Drug Alias NameDW-14383
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 4 antagonistsFibroblast growth factor receptor 1 antagonistsFibroblast growth factor receptor 2 antagonists +[4] 
TargetsFibroblast growth factor receptor 2Fibroblast growth factor receptor 3Fibroblast growth factor receptor 4 +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A